Inactive Instrument
Abliva AB Share Price
Stocks
ABLI
SE0002575340
Biotechnology & Medical Research
OTC Markets Traded| 1 day | +0.23% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 59 | 10/01/2014 | |
Dag Nesse
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/02/2023 |
Magnus Hansson
CTO | Chief Tech/Sci/R&D Officer | 50 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 06/11/2017 | |
| Director/Board Member | 66 | 27/04/2017 | |
David Bejker
BRD | Director/Board Member | 51 | 27/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/03/25 | Sell | Founder | 5,74,978 | 0.0357% | ||
| 07/03/25 | Sell | Founder | 5,74,978 | 0.0357% | ||
| 12/02/25 | Sell | Chief Technology Officer | 31,04,000 | 0.1926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.23% | -1.11% | - | - | 7.6Cr | |
| -2.11% | -3.44% | +41.04% | +98.48% | 6.82TCr | |
| -0.23% | -6.42% | +30.19% | +76.15% | 6.22TCr | |
| +1.59% | +2.69% | -11.04% | +389.38% | 2.78TCr | |
| -1.05% | -7.30% | +25.00% | +12.31% | 2.49TCr | |
| +0.58% | -6.58% | -7.08% | -17.82% | 2.42TCr | |
| +0.43% | -3.37% | +14.85% | -19.29% | 1.94TCr | |
| -3.03% | -5.19% | +192.88% | +340.13% | 1.73TCr | |
| -1.94% | -6.36% | -7.05% | +516.16% | 1.45TCr | |
| -1.72% | -4.39% | +44.41% | +156.57% | 1.42TCr | |
| Average | -0.72% | -3.96% | +35.91% | +172.45% | 3.03TCr | |
| Weighted average by Cap. | -0.81% | -3.80% | +32.91% | +136.99% |
Employees
6
